Zydelig (idelalisib) - Increased Risk Of Fatal And Serious Infections

ZYDELIG Recall Summary Health Canada is recalling the drug ZYDELIG (idelalisib) due to an increased risk of fatal and serious infections in patients taking it. The recall affects ZYDELIG distributed across Canada. This medication is used to treat certain blood cancers and immune conditions.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2016-05-03

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/a279b5b5-83e7-410b-b4ec-d60e084c4ab3